CPT® Code 0590T

Electronic analysis with complex programming of implanted integrated neurostimulation system for bladder dysfunction (eg, electrode array and receiver), including contact group(s), amplitude, pulse width, frequency (Hz), on/off cycling, burst, dose lockout, patient-selectable parameters, responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters, when performed by physician or other qualified health care professional, posterior tibial nerve, 4 or more parameters

The CPT® Code 0590T refers to the electronic analysis with complex programming of an implanted integrated neurostimulation system specifically designed for bladder dysfunction, such as overactive bladder (OAB). This procedure involves the use of a posterior tibial nerve stimulating system, which is a therapeutic approach for managing OAB, a chronic condition characterized by an increased urgency to urinate, frequent urination, and involuntary loss of urine, known as incontinence. The implanted system consists of an electrode array and a receiver that work together to send electrical signals to the posterior tibial nerve. These signals help to modify the communication between the sympathetic and parasympathetic nervous systems, which are crucial in regulating bladder function. The programming of the neurostimulation system is a critical component of the treatment process, as it allows healthcare professionals to adjust various parameters to optimize the device's performance for each individual patient. The complex programming includes adjustments to contact groups, amplitude, pulse width, frequency (measured in Hertz), on/off cycling, burst patterns, dose lockout settings, and patient-selectable parameters. Additionally, the system may incorporate responsive neurostimulation, detection algorithms, closed-loop parameters, and passive parameters to enhance its effectiveness. This comprehensive approach ensures that the neurostimulation system is tailored to meet the specific needs of the patient, thereby improving bladder storage capacity and reducing the symptoms associated with OAB.